Testing effectiveness (Phase 2)Study completedNCT04665843
What this trial is testing
Atezolizumab Plus Tiragolumab and Atezolizumab Plus Placebo as First-Line Treatment in Participants With Recurrent/Metastatic PD-L1 Positive Squamous Cell Carcinoma of the Head and Neck
Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Hoffmann-La Roche 123